Skip Navigation

JNCI Journal of the National Cancer Institute 2006 98(17):1167; doi:10.1093/jnci/djj369
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Japanese Translation
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Request Permissions
Google Scholar
Right arrow Search for Related Content
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© Oxford University Press 2006.

IN THIS ISSUE

The first 10% of the full text of this article appears below.

Gene Expression Profiling for Neuroblastoma, Breast Cancer

The clinical behavior of metastatic neuroblastomas with a nonamplified MYCN gene generally correlates with the patient's age at diagnosis. However, age at diagnosis is not always associated with patient survival. Asgharzadeh et al. (p. 1193) developed a prognostic classifier of disease progression for children diagnosed with metastatic neuroblastomas lacking MYCN gene amplification based on the expression of 55 genes. The classifier identified patients with low and high progression-free survival rates among those older than 12 months at diagnosis with high-risk disease and those older than 18 months at diagnosis. The authors . . . [Full Text of this Article]

Breast Cancer Risk Models Including Breast Density

Use of Lay Health Advisors in Mammography Intervention

Cyclin D1 Overexpression in Breast Cancer and Bortezomib

Radiation-Induced Pneumonitis and CD95


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?